Medtronic (NYSE:MDT) today announced a new real-world retrospective analysis highlighting positive outcomes with its MiniMed ...
A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range (TIR)— ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback